PROCEPT BioRobotics

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, PROCEPT BioRobotics sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 1 currently recruiting 2 completed upper quartile by trial count

PROCEPT BioRobotics: 6 sponsored US clinical trials, 1 recruiting.

PROCEPT BioRobotics sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Localized Prostate Cancer, with 3 trials.

Upper-quartile sponsor footprint

PROCEPT BioRobotics sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the PROCEPT BioRobotics pipeline

1 recruiting of 6 indexed (17% open); 2 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Localized Prostate Cancer (3 trials), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

PROCEPT BioRobotics: open-pipeline peers nationwide

Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

PROCEPT BioRobotics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%20%40%60%80% Total trials Recruiting share PROCEPT BioRobotics23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAdageneAgendiaAkamis BioAngiodynamics
PROCEPT BioRobotics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

PROCEPT BioRobotics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this PROCEPT BioRobotics page

6 registered trials is a research-attention snapshot, not an endorsement of PROCEPT BioRobotics or any single study.

  • 1 of PROCEPT BioRobotics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Localized Prostate Cancer is the condition PROCEPT BioRobotics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Localized Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

PROCEPT BioRobotics pipeline card: 6 registered trials from official public datasets.Report a data error.